Sauter la navigation.


La liste des intervenants de la 3ème édition de Targeting Mitochondria 2012 est maintenant disponible



Au nom du Comité scientifique de Targeting Mitochondria 2012, nous sommes honorés d'accueillir des intervenants de haut niveau qualité pour la troisième édition du congrès international Targeting Mitochondria 2012, qui se tiendra à Berlin, les 8 et 9  Novembre 2012.

Parmi les Conférenciers de l'édition 2012:


Douglas Wallace, Center for Mitochondrial and Epigenomics Medicine, Philadelphia, USA

General Introduction of Targeting Mitochondria 2012: Mitochondria: Huge Steps to New Medicine


Thomas Becker, Institute for Biochemistry and Molecular Biology, Freiburg, Germany

Importing Mitochondrial Proteins: Lessons & Perspectives to Target Mitochondria


Richard Hartley, University of Glasgow, Glasgow, United Kingdom

Targeting Mitochondria by "Magic Molecules": Strategic Role of Chemistry

The MitoB Advantages: a Probe for Assessing Oxidative Stress


Mary Herbert, Institute for Ageing and Health, Newcastle, UK

Mitochondria Gene Replacement & Engineering Mitochondria: New Options and Perspectives for Prevention of Mitochondrial Diseases


Rejko Krüger, University of Tuebingen, Tuebingen, Germany

Targeting Mitochondrial Dynamics as Therapeutic Approach: New Perspectives for Neurodegeneration in Parkinson’s disease


Afshan Malik, King's College London, Diabetes research Group, School of Medicine, London, United Kingdom

Mitochondrial DNA Content and Metabolic/hyperglycaemic Memory: is there a Connection?


Paulo Oliveira, University of Coimbra, Coimbra, Portugal

Mitochondria as a Perfect Drug Target in Health and Disease


Brendan Payne, Institute of Genetic Medicine, Newcastle University, Newcastle, UK

Mitochondrial Aging is Accelerated by Anti-Retroviral Therapy through the Clonal Expansion of mtDNA Mutations


Alessandro Prigione, Max-Planck Institue for Molecular Genetics, Berlin, Germany

Stem Cells, Regenerative Medicine & Mitochondria: Subtle Regulation & Perspectives

iPS Cells (induced Pluripotent Stem Cells) and Mitochondrial Rejuvenation: Fact or Fiction?


Michael Teitell, David Geffen School of Medicine at UCLA, Los Angeles, USA

Correcting Human Mitochondrial Mutations with Targeted RNA Import: Recent Advances and Perspectives for Mitochondria Medicine


Yuma Yamada, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan

Mitochondrial Delivery of Nucleic Acids by DF-MITO-Porter toward Mitochondrial Gene Therapy


Antonio Zorzano, Institute for Research in Biomedicine, Barcelona, Spain

Diabetes and Mitochondria Alteration: Mitofusin 2 as a Potential Target for the Treatment of Diabetes Type 2


Pour plus d'informations: